🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Un webinaire d’information en Français a destination des patients et des familles. Inscription gratuite au: us06web.zoom.us/webinar/regist… ⁦AF3M Asso⁩ ⁦@MyelomaTeacher - Cindy Chmielewski⁩ ⁦Myeloma UK⁩ ⁦Jim Omel⁩ ⁦IACH⁩ ⁦COMy⁩

📰 - We're proud to see our positive Phase 3 Topline results featured in Les Echos. Thank you to Myriam Chauvot from Les Echos for highlighting the promising outcomes of our Phase 3 trial for MaaT013 to treat acute Graft-versus-Host Disease with gastrointestinal involvement

💡 [#WorldCancerDay 2025] - There’s never been a more exciting time in #microbiome #research, especially in #oncology. We’re proud that our ARES trial is contributing to the field, and to a potential breakthrough treatment. Learn more from Professor Mohamad Mohty on what it could

🧠🦠 « Notre intestin dialogue avec notre cerveau » : découvrez les liens entre #microbiote et #santémentale avec Amandine Everard Amandine Everard. Une interview passionnante dans Les Visages de la recherche Via F.R.S.-FNRS ▶️ youtube.com/watch?v=kFBGyo…

Only a fraction of patients respond to immune checkpoint inhibitors Our gut microbiome has key interactions with our immune response to shape the success of cancer immunotherapy Journal of Clinical Investigation: loom.ly/c6sNzu0

The gut and urogenital microbiota play a crucial role in the development and treatment of urogenital infections These are the emerging interventions with promise for targeting the gut-bladder axis: loom.ly/HX054Cc

This #GvHDday, we envision a tomorrow where people with #aGvHD have access to more treatment options and improved outcomes than are available today. This vision drives our work for #patients. Hear more from Professor Mohamad Mohty Mohamad Mohty about why the need is so urgent.

New findings from the Human Phenotype Project show gut microbiome-related pathways and diet were notably predictive of clinical obstructive sleep apnea symptoms, particularly sleepiness Read the research from Eran Segal & colleagues: loom.ly/o8l7Gt4

📅 - [#Event] – Meet Jonathan Chriqui, Chief Business Officer at MaaT Pharma, at #BIOEurope Spring, on March 17-19, 2025, in Milan, Italy. We are eager to connect with global life science leaders and explore new collaboration opportunities. MaaT Pharma is actively seeking to

MaaT Pharma : conclusion positive de l'examen final du DSMB pour l'essai clinique pivotal de Phase 3 évaluant MaaT013 dans la maladie aiguë du greffon contre l'hôte boursier.com/actions/actual… #bourse #finance $MAAT

Microplastic pollution can be detrimental to human, animal, and environmental health Why microplastic research must consider the microbiome: loom.ly/kQJnLVA

📰 [Press release] –MaaT Pharma Stock Initiated with "Buy" Rating by H.C. Wainwright & Co., Target Price Set at €21 H.C. Wainwright & Co. 👉Read the press release here: maatpharma.com/april-47-2025-… #Stock #InvestorRelations #Analysts #Biotech #Investing #Finance #BiotechStocks

Postbiotic supplementation may offer some benefits on inflammation, oxidative stress, and clinical outcomes in patients with background cerebrovascular accidents Read the full clinical trial: nature.com/articles/s4159…

📄 [Communiqué de Presse] - MaaT Pharma annonce des données finales prometteuses pour son essai de Phase 1b évaluant MaaT033 dans la Sclérose Latérale Amyotrophique (SLA) ✅L’essai a atteint son critère principal de sécurité et de tolérabilité ✅Implantation rapide et soutenue

🎥 Dans cette interview, Hervé Affagard, notre CEO et co-fondateur, revient sur les annonces majeures de ce début d’année, notamment les résultats positifs de l’essai de Phase 3 évaluant MaaT013 dans l’aGvH et les prochaines étapes clés de développement de MaaT Pharma. 🎥 In

Highlights from the #GMFH2025 Summit! Experts shared the latest in #microbiome research for diagnosing, preventing & managing GI and extra-intestinal conditions. 🔬 From new diagnostics to personalized care—don’t miss the key takeaways by Andreu Prados gutmicrobiotaforhealth.com/clinical-trans…

Maternal gut microbiota influences immune activation at the maternal-fetal interface affecting pregnancy outcome Maria Rescigno et al. suggest that targeting the gut microbiota may offer a strategy for preventing preeclampsia: loom.ly/jiY9U7I

📢 𝗪𝗼𝗿𝗹𝗱 𝗜𝗕𝗗 𝗗𝗮𝘆 - Another key study just dropped and it confirms the superiority of multidonor product over mono donor ones in Ulcerative Colitis! A new paper recently published in 𝘛𝘦𝘤𝘩𝘯𝘪𝘲𝘶𝘦𝘴 𝘪𝘯 𝘊𝘰𝘭𝘰𝘱𝘳𝘰𝘤𝘵𝘰𝘭𝘰𝘨𝘺, one of the Springer Nature

Understanding the health impacts of local, culturally relevant diets will be critical to advancing precision nutrition This timely editorial in Nature Medicine is worth reading for all researchers in nutrition & microbiome: nature.com/articles/s4159…

📰 [#Média] - MaaT Pharma à l’honneur dans La Tribune ! Merci à Anne Taffin pour cet article qui revient sur notre demande d’autorisation de mise sur le marché auprès de l’Erin pour Xervyteg® (MaaT013), notre candidat-médicament le plus avancé dans le traitement de la maladie